Inventor
Amy Ripka
Inventor
Reading, MA, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes29%
C07KPeptides2%
A61QSpecific use of cosmetics or similar toiletry preparations1%
PatentTitleYear
11,091,497Pyrano[3,4-b]pyrazine kappa opioid receptor ligands for treating addiction, pruritus, pain, and inflammation202110,865,206Inhibitors of cyclin-dependent kinase 7 (CDK7)202010,519,135Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,308,648Inhibitors of cyclin-dependent kinase 7 (CDK7)201910,106,526Inhibitors of cyclin-dependent kinase 7 (CDK7)201810,059,690Inhibitors of cyclin-dependent kinase 7 (CDK7)20189,969,742Imidazotriazinone compounds20189,725,453'Imidazotriazinone compounds'20179,540,380'Imidazotriazinone compounds'20179,486,455'Compounds for modulating TRPV3 function'20169,309,227'N-biphenylmethylbenzimidazole modulators of PPARG'20169,265,767'1,2-disubstituted heterocyclic compounds'20169,181,219'Compounds of modulating TRPV3 function'20158,946,222'Phenoxymethyl heterocyclic compounds'20158,933,074'1,2-disubstituted heterocyclic compounds'20158,916,550'Compounds for modulating TRPV3 function'20148,552,009'Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function'20138,481,532'PDE-10 inhibitors'20138,481,534'5- and 6-membered heterocyclic compounds'20138,466,148'1,2-disubstituted heterocyclic compounds'20138,389,546'Compounds for modulating TRPV3 function'20138,343,973'Phenoxymethyl heterocyclic compounds'20138,163,761'Methods and compositions for treating disorders'20128,071,595'1,2-disubstituted heterocyclic compounds'20117,998,980'Compounds for modulating TRPV3 function'20117,893,260'Substituted quinazolin-4-one compounds for antagonizing TRPV3 function'20117,803,790'Compounds for modulating TRPV3 function'20107,501,404'Substituted azetidinones'20097,041,698'Hepatitis C virus inhibitors'20066,878,722'Substituted cycloalkyl P1′ hepatitis C virus inhibitors'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005Based in Cambridge, MA, US· patent location history
2006Based in Branford, CT, US· patent location history
2009–2011Based in Winthrop, MA, US· patent location history
2010–2016Patents assigned to HYDRA BIOSCIENCES INC (8)· patent assignee history
2010–2021Based in Reading, MA, US· patent location history
2011–2016Patents assigned to RIPKA AMY (9)· patent assignee history
2011–2013Patents assigned to CHESWORTH RICHARD (5)· patent assignee history
2011–2013Patents assigned to ENVIVO PHARMACEUTICALS INC (5)· patent assignee history
2012–2016Patents assigned to FANGER CHRISTOPHER (5)· patent assignee history
2014Based in Wintrop, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIPKA AMYself | 9 | 2011–2016 |
| HYDRA BIOSCIENCES INC | 8 | 2010–2016 |
| CHESWORTH RICHARD | 5 | 2011–2013 |
| ENVIVO PHARMACEUTICALS INC | 5 | 2011–2013 |
| FANGER CHRISTOPHER | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Reading, Massachusetts, US | 25 | 2010–2021 |
| Winthrop, Massachusetts, US | 2 | 2009–2011 |
| Wintrop, Massachusetts, US | 1 | 2014 |
| Branford, CT, US | 1 | 2006 |
| Cambridge, Massachusetts, US | 1 | 2005 |